IFOSFAMIDE — all Canadian products
7 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is IFOSFAMIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02241356 | IFEX | BAXTER CORPORATION | Powder For Solution | Intravenous | IFOSFAMIDE 3 G | Marketed | |
| 02241357 | IFEX | BAXTER CORPORATION | Powder For Solution | Intravenous | IFOSFAMIDE 1 G | Marketed | |
| 00797227 | IFEX PWS 1GM/VIAL | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | Intravenous | IFOSFAMIDE 1 G | Cancelled Post Market | |
| 00797235 | IFEX PWS 2G/VIAL | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | Intravenous | IFOSFAMIDE 2 G | Cancelled Post Market | |
| 00808601 | IFEX PWS 3GM/VIAL | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | Intravenous | IFOSFAMIDE 3 G | Cancelled Post Market | |
| 02246566 | IFOSFAMIDE FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | IFOSFAMIDE 3 G | Cancelled Pre Market | |
| 02246565 | IFOSFAMIDE FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | IFOSFAMIDE 1 G | Cancelled Post Market |
Browse other molecules: